Tectonic Advisors LLC Grows Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Tectonic Advisors LLC raised its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 11.5% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 41,269 shares of the company’s stock after buying an additional 4,260 shares during the quarter. Tectonic Advisors LLC’s holdings in Procter & Gamble were worth $7,148,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Acorn Creek Capital LLC grew its holdings in Procter & Gamble by 2.8% in the third quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock valued at $376,000 after purchasing an additional 59 shares during the last quarter. Patrick M Sweeney & Associates Inc. grew its holdings in Procter & Gamble by 1.1% in the third quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock valued at $963,000 after purchasing an additional 59 shares during the last quarter. Alera Investment Advisors LLC grew its holdings in Procter & Gamble by 1.2% in the first quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock valued at $812,000 after purchasing an additional 60 shares during the last quarter. Hudson Value Partners LLC grew its holdings in Procter & Gamble by 4.1% in the second quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock valued at $250,000 after purchasing an additional 60 shares during the last quarter. Finally, Traveka Wealth LLC grew its holdings in Procter & Gamble by 1.7% in the third quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after purchasing an additional 60 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Stock Performance

Procter & Gamble stock opened at $169.64 on Friday. The stock’s 50-day moving average is $171.88 and its 200-day moving average is $167.45. The company has a market cap of $399.51 billion, a price-to-earnings ratio of 29.25, a price-to-earnings-growth ratio of 3.67 and a beta of 0.41. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The Procter & Gamble Company has a 12 month low of $142.50 and a 12 month high of $177.94.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company’s quarterly revenue was down .6% compared to the same quarter last year. During the same period last year, the business posted $1.83 EPS. Equities analysts anticipate that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a dividend of $1.0065 per share. The ex-dividend date is Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.37%. Procter & Gamble’s payout ratio is currently 69.48%.

Insider Activity at Procter & Gamble

In related news, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the sale, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In related news, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the sale, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO R. Alexandra Keith sold 3,373 shares of the firm’s stock in a transaction dated Monday, August 5th. The shares were sold at an average price of $170.00, for a total value of $573,410.00. Following the sale, the chief executive officer now owns 21,513 shares in the company, valued at approximately $3,657,210. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 385,186 shares of company stock worth $65,479,358. 0.18% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

PG has been the topic of several recent research reports. TD Cowen initiated coverage on Procter & Gamble in a research report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price objective on the stock. Deutsche Bank Aktiengesellschaft upped their price objective on Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. JPMorgan Chase & Co. upped their price objective on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. Piper Sandler initiated coverage on Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective on the stock. Finally, Jefferies Financial Group downgraded Procter & Gamble from a “buy” rating to a “hold” rating and reduced their price objective for the company from $182.00 to $175.00 in a research report on Wednesday, July 24th. Nine equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $177.00.

Check Out Our Latest Analysis on PG

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

See Also

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.